DIOVAN
Dead / Cancelled — Cancelled — Section 8 (as of 19 Feb 2021)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77527298
- Registration number
- 3819018
- Mark type
- Design + words
- Filed
- 21 Jul 2008
- Published for opposition
- 16 Dec 2008
- Registered
- 13 Jul 2010
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention of disorders of the cardiovascular system; Pharmaceutical preparations for the treatment of disorders of the cardiovascular system
Owner
- Novartis Corporation, Summit, NJ, US
- Novartis Corporation, Summit, NJ, US
- Novartis Corporation, Summit, NJ, US
Prior registrations
Prosecution history
- 19 Feb 2021 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 08 Jul 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
- 08 Jul 2016 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Jul 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Apr 2016 — TEAS SECTION 8 & 15 RECEIVED
- 13 Jul 2010 — REGISTERED-PRINCIPAL REGISTER
- 08 Jun 2010 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Jun 2010 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 02 Jun 2010 — ASSIGNED TO LIE
- 06 Apr 2010 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Apr 2010 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Mar 2010 — USE AMENDMENT FILED
- 02 Apr 2010 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Mar 2010 — TEAS STATEMENT OF USE RECEIVED
- 09 Sept 2009 — SOU EXTENSION 1 GRANTED